{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:42:04Z","timestamp":1790224924366,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T00:00:00Z","timestamp":1294185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12016-010-8222-2","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T03:40:20Z","timestamp":1294112420000},"page":"151-162","source":"Crossref","is-referenced-by-count":36,"title":["Cutting Edge Issues in Goodpasture\u2019s Disease"],"prefix":"10.1007","volume":"41","author":[{"given":"Andrew L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin O.","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya M.","family":"Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Albertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"key":"8222_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imj.1958.7.2.132","volume":"7","author":"MC Stanton","year":"1958","unstructured":"Stanton MC, Tange JD (1958) Goodpasture\u2019s syndrome (pulmonary haemorrhage associated with glomerulonephritis). Australas Ann Med 7:132\u2013144","journal-title":"Australas Ann Med"},{"key":"8222_CR2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000441-191911000-00012","volume":"158","author":"EW Goodpasture","year":"1919","unstructured":"Goodpasture EW (1919) The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158:863\u2013870","journal-title":"Am J Med Sci"},{"key":"8222_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.anndiagpath.2010.02.003","volume":"14","author":"RD Collins","year":"2010","unstructured":"Collins RD (2010) Dr Goodpasture: \u201cI was not aware of such a connection between lung and kidney disease\u201d. Ann Diagn Pathol 14:194\u2013198","journal-title":"Ann Diagn Pathol"},{"key":"8222_CR4","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1056\/NEJMra022296","volume":"348","author":"BG Hudson","year":"2003","unstructured":"Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG (2003) Alport\u2019s syndrome, Goodpasture\u2019s syndrome, and type IV collagen. N Engl J Med 348:2543\u20132556","journal-title":"N Engl J Med"},{"key":"8222_CR5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1681\/ASN.V1291908","volume":"12","author":"AD Salama","year":"2001","unstructured":"Salama AD, Chaudhry AN, Ryan JJ, Eren E, Levy JB, Pusey CD et al (2001) In Goodpasture\u2019s disease, CD4(+) T cells escape thymic deletion and are reactive with the autoantigen alpha3(IV)NC1. J Am Soc Nephrol 12:1908\u20131915","journal-title":"J Am Soc Nephrol"},{"key":"8222_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0140-6736(01)06077-9","volume":"358","author":"AD Salama","year":"2001","unstructured":"Salama AD, Levy JB, Lightstone L, Pusey CD (2001) Goodpasture\u2019s disease. Lancet 358:917\u2013920","journal-title":"Lancet"},{"key":"8222_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.autrev.2010.05.012","volume":"9","author":"RW Lee","year":"2010","unstructured":"Lee RW, D\u2019Cruz DP (2010) Pulmonary renal vasculitis syndromes. Autoimmun Rev 9:657\u2013660","journal-title":"Autoimmun Rev"},{"key":"8222_CR8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1046\/j.1523-1755.2003.00241.x","volume":"64","author":"CD Pusey","year":"2003","unstructured":"Pusey CD (2003) Anti-glomerular basement membrane disease. Kidney Int 64:1535\u20131550","journal-title":"Kidney Int"},{"key":"8222_CR9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/md.0b013e318067da56","volume":"86","author":"R Lazor","year":"2007","unstructured":"Lazor R, Bigay-Game L, Cottin V, Cadranel J, Decaux O, Fellrath JM et al (2007) Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore) 86:181\u2013193","journal-title":"Medicine (Baltimore)"},{"key":"8222_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/08860229609052780","volume":"18","author":"C Daly","year":"1996","unstructured":"Daly C, Conlon PJ, Medwar W, Walshe JJ (1996) Characteristics and outcome of anti-glomerular basement membrane disease: a single-center experience. Ren Fail 18:105\u2013112","journal-title":"Ren Fail"},{"key":"8222_CR11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmj.292.6516.301","volume":"292","author":"CO Savage","year":"1986","unstructured":"Savage CO, Pusey CD, Bowman C, Rees AJ, Lockwood CM (1986) Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) 292:301\u2013304","journal-title":"Br Med J (Clin Res Ed)"},{"key":"8222_CR12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7326\/0003-4819-134-11-200106050-00009","volume":"134","author":"JB Levy","year":"2001","unstructured":"Levy JB, Turner AN, Rees AJ, Pusey CD (2001) Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med 134:1033\u20131042","journal-title":"Ann Intern Med"},{"key":"8222_CR13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jaut.2008.04.005","volume":"31","author":"JD Ooi","year":"2008","unstructured":"Ooi JD, Holdsworth SR, Kitching AR (2008) Advances in the pathogenesis of Goodpasture\u2019s disease: from epitopes to autoantibodies to effector T cells. J Autoimmun 31:295\u2013300","journal-title":"J Autoimmun"},{"key":"8222_CR14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(83)90923-6","volume":"2","author":"M Donaghy","year":"1983","unstructured":"Donaghy M, Rees AJ (1983) Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet 2:1390\u20131393","journal-title":"Lancet"},{"key":"8222_CR15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/0002-9343(88)90114-3","volume":"84","author":"RJ Klasa","year":"1988","unstructured":"Klasa RJ, Abboud RT, Ballon HS, Grossman L (1988) Goodpasture\u2019s syndrome: recurrence after a five-year remission. Case report and review of the literature. Am J Med 84:751\u2013755","journal-title":"Am J Med"},{"key":"8222_CR16","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1440-1827.1997.tb04443.x","volume":"47","author":"GM Garcia-Rostan y Perez","year":"1997","unstructured":"Garcia-Rostan y Perez GM, Garcia Bragado F, Puras Gil AM (1997) Pulmonary hemorrhage and antiglomerular basement membrane antibody-mediated glomerulonephritis after exposure to smoked cocaine (crack): a case report and review of the literature. Pathol Int 47:692\u2013697","journal-title":"Pathol Int"},{"key":"8222_CR17","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1378\/chest.103.3.956","volume":"103","author":"P Lechleitner","year":"1993","unstructured":"Lechleitner P, Defregger M, Lhotta K, Totsch M, Fend F (1993) Goodpasture\u2019s syndrome. Unusual presentation after exposure to hard metal dust. Chest 103:956\u2013957","journal-title":"Chest"},{"key":"8222_CR18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00039896.1972.10666187","volume":"25","author":"GJ Beirne","year":"1972","unstructured":"Beirne GJ, Brennan JT (1972) Glomerulonephritis associated with hydrocarbon solvents: mediated by antiglomerular basement membrane antibody. Arch Environ Health 25:365\u2013369","journal-title":"Arch Environ Health"},{"key":"8222_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajim.4700210204","volume":"21","author":"GJ Bombassei","year":"1992","unstructured":"Bombassei GJ, Kaplan AA (1992) The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture\u2019s syndrome). Am J Ind Med 21:141\u2013153","journal-title":"Am J Ind Med"},{"key":"8222_CR20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4049\/jimmunol.114.1_Part_2.306","volume":"114","author":"WT Blue","year":"1975","unstructured":"Blue WT, Lange CF (1975) Increased immunologic reactivity between human glomerular basement membrane and group A type 12 streptococcal cell membrane after carbohydrase treatment. J Immunol 114:306\u2013309","journal-title":"J Immunol"},{"key":"8222_CR21","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1046\/j.1523-1755.1999.00720.x","volume":"56","author":"RG Phelps","year":"1999","unstructured":"Phelps RG, Rees AJ (1999) The HLA complex in Goodpasture\u2019s disease: a model for analyzing susceptibility to autoimmunity. Kidney Int 56:1638\u20131653","journal-title":"Kidney Int"},{"key":"8222_CR22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ki.1996.163","volume":"49","author":"F Merkel","year":"1996","unstructured":"Merkel F, Kalluri R, Marx M, Enders U, Stevanovic S, Giegerich G et al (1996) Autoreactive T-cells in Goodpasture\u2019s syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int 49:1127\u20131133","journal-title":"Kidney Int"},{"key":"8222_CR23","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1046\/j.1523-1755.2001.00014.x","volume":"60","author":"D Wong","year":"2001","unstructured":"Wong D, Phelps RG, Turner AN (2001) The Goodpasture antigen is expressed in the human thymus. Kidney Int 60:1777\u20131783","journal-title":"Kidney Int"},{"key":"8222_CR24","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1681\/ASN.2004100837","volume":"16","author":"D Wolf","year":"2005","unstructured":"Wolf D, Hochegger K, Wolf AM, Rumpold HF, Gastl G, Tilg H et al (2005) CD4 + CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 16:1360\u20131370","journal-title":"J Am Soc Nephrol"},{"key":"8222_CR25","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1046\/j.1523-1755.2003.00259.x","volume":"64","author":"AD Salama","year":"2003","unstructured":"Salama AD, Chaudhry AN, Holthaus KA, Mosley K, Kalluri R, Sayegh MH et al (2003) Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture\u2019s (anti-GBM) disease. Kidney Int 64:1685\u20131694","journal-title":"Kidney Int"},{"key":"8222_CR26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.4049\/jimmunol.167.4.2388","volume":"167","author":"J Wu","year":"2001","unstructured":"Wu J, Hicks J, Ou C, Singleton D, Borillo J, Lou YH (2001) Glomerulonephritis induced by recombinant collagen IV alpha 3 chain noncollagen domain 1 is not associated with glomerular basement membrane antibody: a potential T cell-mediated mechanism. J Immunol 167:2388\u20132395","journal-title":"J Immunol"},{"key":"8222_CR27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI13876","volume":"109","author":"J Wu","year":"2002","unstructured":"Wu J, Hicks J, Borillo J, Glass WF 2nd, Lou YH (2002) CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 109:517\u2013524","journal-title":"J Clin Invest"},{"key":"8222_CR28","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1172\/JCI119764","volume":"100","author":"R Kalluri","year":"1997","unstructured":"Kalluri R, Danoff TM, Okada H, Neilson EG (1997) Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice. J Clin Invest 100:2263\u20132275","journal-title":"J Clin Invest"},{"key":"8222_CR29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1681\/ASN.V132359","volume":"13","author":"J Reynolds","year":"2002","unstructured":"Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD (2002) Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol 13:359\u2013369","journal-title":"J Am Soc Nephrol"},{"key":"8222_CR30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1523-1755.2004.00907.x","volume":"66","author":"J Reynolds","year":"2004","unstructured":"Reynolds J, Khan SB, Allen AR, Benjamin CD, Pusey CD (2004) Blockade of the CD154-CD40 costimulatory pathway prevents the development of experimental autoimmune glomerulonephritis. Kidney Int 66:1444\u20131452","journal-title":"Kidney Int"},{"key":"8222_CR31","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/ndt\/5.12.991","volume":"5","author":"M Segelmark","year":"1990","unstructured":"Segelmark M, Butkowski R, Wieslander J (1990) Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant 5:991\u2013996","journal-title":"Nephrol Dial Transplant"},{"key":"8222_CR32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V641178","volume":"6","author":"R Kalluri","year":"1995","unstructured":"Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG et al (1995) Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6:1178\u20131185","journal-title":"J Am Soc Nephrol"},{"key":"8222_CR33","doi-asserted-by":"crossref","first-page":"13374","DOI":"10.1016\/S0021-9258(18)37714-7","volume":"263","author":"J Saus","year":"1988","unstructured":"Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG (1988) Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263:13374\u201313380","journal-title":"J Biol Chem"},{"key":"8222_CR34","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1073\/pnas.81.12.3838","volume":"81","author":"J Wieslander","year":"1984","unstructured":"Wieslander J, Barr JF, Butkowski RJ, Edwards SJ, Bygren P, Heinegard D et al (1984) Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci USA 81:3838\u20133842","journal-title":"Proc Natl Acad Sci USA"},{"key":"8222_CR35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR et al (2010) Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med 363:343\u2013354","journal-title":"N Engl J Med"},{"key":"8222_CR36","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1056\/NEJMe1006301","volume":"363","author":"DJ Salant","year":"2010","unstructured":"Salant DJ (2010) Goodpasture\u2019s disease\u2014new secrets revealed. N Engl J Med 363:388\u2013391","journal-title":"N Engl J Med"},{"key":"8222_CR37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI115625","volume":"89","author":"N Turner","year":"1992","unstructured":"Turner N, Mason PJ, Brown R, Fox M, Povey S, Rees A et al (1992) Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest 89:592\u2013601","journal-title":"J Clin Invest"},{"key":"8222_CR38","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1046\/j.1523-1755.1998.00153.x","volume":"54","author":"M Abbate","year":"1998","unstructured":"Abbate M, Kalluri R, Corna D, Yamaguchi N, McCluskey RT, Hudson BG et al (1998) Experimental Goodpasture\u2019s syndrome in Wistar-Kyoto rats immunized with alpha3 chain of type IV collagen. Kidney Int 54:1550\u20131561","journal-title":"Kidney Int"},{"key":"8222_CR39","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1074\/jbc.271.15.9062","volume":"271","author":"R Kalluri","year":"1996","unstructured":"Kalluri R, Sun MJ, Hudson BG, Neilson EG (1996) The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen. J Biol Chem 271:9062\u20139068","journal-title":"J Biol Chem"},{"key":"8222_CR40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000060181","volume":"136","author":"CE Kashtan","year":"2001","unstructured":"Kashtan CE (2001) Familial hematuric syndromes\u2014Alport syndrome, thin glomerular basement membrane disease and Fechtner\/Epstein syndromes. Contrib Nephrol 136:79\u201399","journal-title":"Contrib Nephrol"},{"key":"8222_CR41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1081\/JDI-100101961","volume":"22","author":"JP Grunfeld","year":"2000","unstructured":"Grunfeld JP (2000) Contemporary diagnostic approach in Alport\u2019s syndrome. Ren Fail 22:759\u2013763","journal-title":"Ren Fail"},{"key":"8222_CR42","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(61)90899-6","volume":"2","author":"DA Williamson","year":"1961","unstructured":"Williamson DA (1961) Alport\u2019s syndrome of hereditary nephritis with deafness. Lancet 2:1321\u20131323","journal-title":"Lancet"},{"key":"8222_CR43","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/ki.1996.459","volume":"50","author":"CE Kashtan","year":"1996","unstructured":"Kashtan CE, Michael AF (1996) Alport syndrome. Kidney Int 50:1445\u20131463","journal-title":"Kidney Int"},{"key":"8222_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/ki.1992.276","volume":"42","author":"BG Hudson","year":"1992","unstructured":"Hudson BG, Kalluri R, Gunwar S, Weber M, Ballester F, Hudson JK et al (1992) The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation. Kidney Int 42:179\u2013187","journal-title":"Kidney Int"},{"key":"8222_CR45","doi-asserted-by":"crossref","first-page":"10670","DOI":"10.1074\/jbc.M611892200","volume":"282","author":"JS Kang","year":"2007","unstructured":"Kang JS, Kashtan CE, Turner AN, Heidet L, Hudson BG, Borza DB (2007) The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain. J Biol Chem 282:10670\u201310677","journal-title":"J Biol Chem"},{"key":"8222_CR46","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00007890-200002270-00038","volume":"69","author":"R Kalluri","year":"2000","unstructured":"Kalluri R, Torre A, Shield CF 3rd, Zamborsky ED, Werner MC, Suchin E et al (2000) Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies. Transplantation 69:679\u2013683","journal-title":"Transplantation"},{"key":"8222_CR47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1399-3046.2006.00528.x","volume":"10","author":"CE Kashtan","year":"2006","unstructured":"Kashtan CE (2006) Renal transplantation in patients with Alport syndrome. Pediatr Transplant 10:651\u2013657","journal-title":"Pediatr Transplant"},{"key":"8222_CR48","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2249.1997.4261438.x","volume":"110","author":"NS Sheerin","year":"1997","unstructured":"Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH (1997) Protection against anti-glomerular basement membrane (GBM)-mediated nephritis in C3- and C4-deficient mice. Clin Exp Immunol 110:403\u2013409","journal-title":"Clin Exp Immunol"},{"key":"8222_CR49","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0003-9861(91)90222-5","volume":"288","author":"WH Baricos","year":"1991","unstructured":"Baricos WH, Cortez SL, Le QC, Wu LT, Shaw E, Hanada K et al (1991) Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis. Arch Biochem Biophys 288:468\u2013472","journal-title":"Arch Biochem Biophys"},{"key":"8222_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<1::AID-IMMU1>3.0.CO;2-R","volume":"29","author":"AR Kitching","year":"1999","unstructured":"Kitching AR, Tipping PG, Holdsworth SR (1999) IL-12 directs severe renal injury, crescent formation and Th1 responses in murine glomerulonephritis. Eur J Immunol 29:1\u201310","journal-title":"Eur J Immunol"},{"key":"8222_CR51","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.168.8.4135","volume":"168","author":"JR Timoshanko","year":"2002","unstructured":"Timoshanko JR, Holdsworth SR, Kitching AR, Tipping PG (2002) IFN-gamma production by intrinsic renal cells and bone marrow-derived cells is required for full expression of crescentic glomerulonephritis in mice. J Immunol 168:4135\u20134141","journal-title":"J Immunol"},{"key":"8222_CR52","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","volume":"339","author":"G Remuzzi","year":"1998","unstructured":"Remuzzi G, Bertani T (1998) Pathophysiology of progressive nephropathies. N Engl J Med 339:1448\u20131456","journal-title":"N Engl J Med"},{"key":"8222_CR53","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1681\/ASN.V10112446","volume":"10","author":"DC Kluth","year":"1999","unstructured":"Kluth DC, Rees AJ (1999) Anti-glomerular basement membrane disease. J Am Soc Nephrol 10:2446\u20132453","journal-title":"J Am Soc Nephrol"},{"key":"8222_CR54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","volume":"137","author":"AR Lara","year":"2010","unstructured":"Lara AR, Schwarz MI (2010) Diffuse alveolar hemorrhage. Chest 137:1164\u20131171","journal-title":"Chest"},{"key":"8222_CR55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00005792-199705000-00005","volume":"76","author":"MR Zamora","year":"1997","unstructured":"Zamora MR, Warner ML, Tuder R, Schwarz MI (1997) Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76:192\u2013202","journal-title":"Medicine (Baltimore)"},{"key":"8222_CR56","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ndt\/13.4.935","volume":"13","author":"C Ang","year":"1998","unstructured":"Ang C, Savige J, Dawborn J, Miach P, Heale W, Clarke B et al (1998) Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant 13:935\u2013939","journal-title":"Nephrol Dial Transplant"},{"key":"8222_CR57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00108-005-1423-8","volume":"46","author":"K Groot de","year":"2005","unstructured":"de Groot K, Schnabel A (2005) Pulmonary-renal syndrome. Internist (Berl) 46:769\u2013781, quiz 782","journal-title":"Internist (Berl)"},{"key":"8222_CR58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jaut.2009.02.008","volume":"32","author":"R Cervera","year":"2009","unstructured":"Cervera R, Bucciarelli S, Plasin MA, Gomez-Puerta JA, Plaza J, Pons-Estel G et al (2009) Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the \u201cCAPS Registry\u201d. J Autoimmun 32:240\u2013245","journal-title":"J Autoimmun"},{"key":"8222_CR59","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1378\/chest.91.6.891","volume":"91","author":"JW Leatherman","year":"1987","unstructured":"Leatherman JW (1987) Immune alveolar hemorrhage. Chest 91:891\u2013897","journal-title":"Chest"},{"key":"8222_CR60","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/ajkd.2002.33385","volume":"39","author":"AD Salama","year":"2002","unstructured":"Salama AD, Dougan T, Levy JB, Cook HT, Morgan SH, Naudeer S et al (2002) Goodpasture\u2019s disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis 39:1162\u20131167","journal-title":"Am J Kidney Dis"},{"key":"8222_CR61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ndt\/gfi230","volume":"21","author":"RA Sinico","year":"2006","unstructured":"Sinico RA, Radice A, Corace C, Sabadini E, Bollini B (2006) Anti-glomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: a comparison of different assays. Nephrol Dial Transplant 21:397\u2013401","journal-title":"Nephrol Dial Transplant"},{"key":"8222_CR62","first-page":"599","volume-title":"Nephrology","author":"JB Levy","year":"1997","unstructured":"Levy JB, Pusey CD (1997) Anti-GBM antibody mediated disease. In: Wilkinson R Jr (ed) Nephrology. Chapman & Hall, London, pp 599\u2013615"},{"key":"8222_CR63","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000186473","volume":"58","author":"P Gris","year":"1991","unstructured":"Gris P, Pirson Y, Hamels J, Vaerman JP, Quoidbach A, Demol H (1991) Antiglomerular basement membrane nephritis induced by IgA1 antibodies. Nephron 58:418\u2013424","journal-title":"Nephron"},{"key":"8222_CR64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1523-1755.2000.00146.x","volume":"58","author":"A Rutgers","year":"2000","unstructured":"Rutgers A, Meyers KE, Canziani G, Kalluri R, Lin J, Madaio MP (2000) High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen. Kidney Int 58:115\u2013122","journal-title":"Kidney Int"},{"key":"8222_CR65","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/ki.1974.57","volume":"5","author":"CB Wilson","year":"1974","unstructured":"Wilson CB, Dixon FJ (1974) Diagnosis of immunopathologic renal disease. Kidney Int 5:389\u2013401","journal-title":"Kidney Int"},{"key":"8222_CR66","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD (2004) Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int 66:1535\u20131540","journal-title":"Kidney Int"},{"key":"8222_CR67","first-page":"107","volume":"36","author":"X Bosch","year":"1991","unstructured":"Bosch X, Mirapeix E, Font J, Borrellas X, Rodriguez R, Lopez-Soto A et al (1991) Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease. Clin Nephrol 36:107\u2013113","journal-title":"Clin Nephrol"},{"key":"8222_CR68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0046-8177(89)90009-9","volume":"20","author":"CM Lombard","year":"1989","unstructured":"Lombard CM, Colby TV, Elliott CG (1989) Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture\u2019s syndrome. Hum Pathol 20:445\u2013451","journal-title":"Hum Pathol"},{"key":"8222_CR69","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.me.31.020180.001123","volume":"31","author":"CM Lockwood","year":"1980","unstructured":"Lockwood CM, Peters DK (1980) Plasma exchange in glomerulonephritis and related vasculitides. Annu Rev Med 31:167\u2013179","journal-title":"Annu Rev Med"},{"key":"8222_CR70","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0272-6386(12)80135-1","volume":"23","author":"MH Mokrzycki","year":"1994","unstructured":"Mokrzycki MH, Kaplan AA (1994) Therapeutic plasma exchange: complications and management. Am J Kidney Dis 23:817\u2013827","journal-title":"Am J Kidney Dis"},{"key":"8222_CR71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(76)93089-0","volume":"1","author":"CM Lockwood","year":"1976","unstructured":"Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB (1976) Immunosuppression and plasma-exchange in the treatment of Goodpasture\u2019s syndrome. Lancet 1:711\u2013715","journal-title":"Lancet"},{"key":"8222_CR72","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/oxfordjournals.ndt.a027889","volume":"13","author":"KO Netzer","year":"1998","unstructured":"Netzer KO, Merkel F, Weber M (1998) Goodpasture syndrome and end-stage renal failure\u2013to transplant or not to transplant? Nephrol Dial Transplant 13:1346\u20131348","journal-title":"Nephrol Dial Transplant"},{"key":"8222_CR73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(96)90169-9","volume":"27","author":"JB Levy","year":"1996","unstructured":"Levy JB, Lachmann RH, Pusey CD (1996) Recurrent Goodpasture\u2019s disease. Am J Kidney Dis 27:573\u2013578","journal-title":"Am J Kidney Dis"},{"key":"8222_CR74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1172\/JCI6710","volume":"105","author":"J Reynolds","year":"2000","unstructured":"Reynolds J, Tam FW, Chandraker A, Smith J, Karkar AM, Cross J et al (2000) CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 105:643\u2013651","journal-title":"J Clin Invest"},{"key":"8222_CR75","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/ajkd.2000.8993","volume":"36","author":"K Laczika","year":"2000","unstructured":"Laczika K, Knapp S, Derfler K, Soleiman A, Horl WH, Druml W (2000) Immunoadsorption in Goodpasture\u2019s syndrome. Am J Kidney Dis 36:392\u2013395","journal-title":"Am J Kidney Dis"},{"key":"8222_CR76","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1160\/TH10-02-0138","volume":"104","author":"S Lovric","year":"2010","unstructured":"Lovric S, Lukasz A, Hafer C, Kielstein JT, Haubitz M, Haller H et al (2010) Removal of elevated circulating angiopoietin-2 by plasma exchange\u2014a pilot study in critically ill patients with thrombotic microangiopathy and anti-glomerular basement membrane disease. Thromb Haemost 104:1038\u20131043","journal-title":"Thromb Haemost"},{"key":"8222_CR77","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/eji.1830270226","volume":"27","author":"PG Tipping","year":"1997","unstructured":"Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR (1997) Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27:530\u2013537","journal-title":"Eur J Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8222-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8222-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8222-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:36:26Z","timestamp":1685903786000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8222-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["8222"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8222-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,5]]}}}